MEDINET Co Ltd Sustainability Reports
MEDINET Co., Ltd. provides cell manufacturing services and comprehensive support for immune cell therapies, operating contract development and manufacturing organization (CDMO) services for regenerative medicine products.
Sector: Manufacturing
Country: Japan
Exchange: Tokyo Stock Exchange
FIGI: BBG001S8LGC7
5 reports from 2021 to 2025
Company Profile
MEDINET Co., Ltd. provides cell manufacturing services and comprehensive support for immune cell therapies, operating contract development and manufacturing organization (CDMO) services for regenerative medicine products.
Reports
5 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
